When it comes to knowledge of the Middle East and Africa region’s pharmaceutical industry, few executives have the experience of Dr Alaa Gamal.…

The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for…

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in the latest national budget;…

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…

Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years, what other Pfizer affiliates can…

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the past year. From Mexico to Morocco…

The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of successful COVID-19 trial results from…

During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech executives spoke about the changing…